The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
EN400 episodes
education
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Notable Guests
Episodes (400)
EULAR 2024 Highlights: Day 4
The IMID Forum
Jun 15, 20242:44pending
EULAR 2024 Highlights: Day 3
The IMID Forum
Jun 14, 20244:25pending
EULAR 2024 Highlights: Day 2
The IMID Forum
Jun 13, 20244:00pending
EULAR 2024 Highlights: Day 1
The IMID Forum
Jun 12, 20245:09pending
EULAR 2024 Preview Podcast
The IMID Forum
Jun 10, 202414:00pending
Discussing RA: May 2024
The IMID Forum
Jun 6, 202430:08pending
IMID Author Interview: Dorthe Berthelsen, 2024
The IMID Forum
May 14, 202423:26pending
Webinar Highlights Podcast: Evolving Therapeutic Strategies for Psoriatic Diseas...
The IMID Forum
May 7, 202429:42pending
IMID Author Interview: Dr Jake Weddell, 2024
The IMID Forum
May 7, 202421:01pending
IMID Author Interview: Professor Frank Verhoeven, 2024
The IMID Forum
Apr 30, 202420:36pending
Discussing RA: April 2024
The IMID Forum
Apr 25, 202411:12pending
Author Interview: Professor Maria Antonietta D’Agostino, 2024
The IMID Forum
Apr 18, 202422:15pending
Author Interview: Professor Dennis McGonagle, 2024
The IMID Forum
Apr 16, 202431:18pending
Author Interview: Dr Jürgen Rech, 2024
The IMID Forum
Apr 4, 202432:30pending
Author Interview: Dr Mahta Mortezavi, 2024
The IMID Forum
Feb 28, 202420:18pending
Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John...
The IMID Forum
Feb 26, 202443:10pending
Author Interview: Dr Kehinde Sunmboye, 2024
The IMID Forum
Feb 15, 202418:05pending
Author Interview: Professor Andrea Rubbert-Roth, 2023
The IMID Forum
Jan 22, 202425:17pending
Discussing Rheumatology: December 2023
The IMID Forum
Dec 22, 202310:37pending
PsA Podcast: Impact of Biological Sex on Advanced Therapies & Upadacitinib-relat...
The IMID Forum
Dec 22, 202327:19pending
AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab
The IMID Forum
Dec 4, 202333:10pending
AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab
The IMID Forum
Dec 1, 202333:10pending
PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treati...
The IMID Forum
Dec 1, 202321:09pending
Discussing Rheumatology: November 2023
The IMID Forum
Nov 23, 202310:11pending
ACR 2023 Highlights: Day 4
The IMID Forum
Nov 15, 20232:33pending
ACR 2023 Highlights: Day 3
The IMID Forum
Nov 14, 20233:40pending
ACR 2023 Highlights: Day 2
The IMID Forum
Nov 13, 20233:20pending
ACR 2023 Highlights: Day 1
The IMID Forum
Nov 12, 20236:15pending
ACR 2023 Preview Podcast
The IMID Forum
Nov 9, 20238:43pending
Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and...
The IMID Forum
Oct 31, 202321:21pending
axSpA Podcast: Safety and Efficacy of Upadacitinib
The IMID Forum
Oct 26, 202326:31pending
CSF Author Interview: Dr. David Martin, 2023
The IMID Forum
Oct 26, 202339:27pending
Discussing Rheumatology: October 2023
The IMID Forum
Oct 20, 202311:17pending
EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas Kersc...
The IMID Forum
Oct 16, 202335:13pending
CSF Author Interview: Professor Martin Bergman, 2023
The IMID Forum
Oct 11, 202327:25pending
Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib...
The IMID Forum
Oct 11, 202331:28pending
AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab
The IMID Forum
Sep 25, 202325:40pending
Discussing Rheumatology: September 2023
The IMID Forum
Sep 25, 202311:13pending
Author Interview: Sofia Ramiro
The IMID Forum
Aug 31, 202324:19pending
Discussing Rheumatology: August 2023
The IMID Forum
Aug 22, 20238:12pending
AxSpA Podcast: Tofacitinib, Golimumab, and Fatigue
The IMID Forum
Aug 16, 202319:21pending
Discussing Rheumatology: July 2023
The IMID Forum
Jul 19, 202310:22pending
PsA Podcast: Secukinumab in Oligoarticular PsA & JAK Inhibition-related Malignan...
The IMID Forum
Jul 12, 202332:46pending
Author Interview: Laura Coates
The IMID Forum
Jul 10, 202328:43pending
Author Interview: Mark Russell
The IMID Forum
Jul 7, 202330:21pending
Discussing Rheumatology: June 2023
The IMID Forum
Jun 26, 20239:48pending
AxSpA Podcast: Secukinumab Optimisation & Ixekizumab Treatment for PAEs
The IMID Forum
Jun 14, 202322:00pending
EULAR 2023 Highlights: Day 4
The IMID Forum
Jun 3, 202318:54pending
EULAR 2023 Highlights: Day 3
The IMID Forum
Jun 2, 202327:24pending
EULAR 2023 Highlights: Day 2
The IMID Forum
Jun 1, 202316:14pending
...